Search - tctmd.com

Displaying 21 - 40 of 117

Sort: Relevancy | Date

Presentation TVT 2017

Who Shouldnt Undergo TAVR? Can We Identify Non-responders?

Presenter: David J. Cohen, Mark J. Russo, Suzanne V. Arnold

June 16, 2017

Presentation TVT 2017

Ineffective Endocarditis After TAVR: Cause for Concern?

Presenter: David J. Cohen, Mark J. Russo, Bernard Prendergast

June 16, 2017

Presentation TVT 2017

Gender Differences in TAVR Outcomes Recent Analyses in Intermediate-Risk Patients

Presenter: David J. Cohen, Mark J. Russo, Molly Szerlip

June 16, 2017

Presentation TVT 2017

TAVR in Patients With CKD: Diagnostic Workup, Valve Sizing, and Other Procedural Adjustments

Presenter: Howard C. Herrmann

June 16, 2017

Presentation TVT 2017

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Presenter: Samir R. Kapadia

June 16, 2017

Presentation TVT 2017

Management of Acute Coronary Syndromes and Left Main CAD in AS Patients: Case Examples and Procedural Techniques

Presenter: Raj Makkar

June 16, 2017

Presentation TVT 2017

Management of Stable Coronary Disease in AS Patients: Evolving Treatment Considerations (When to Consider CABG, Timing of PCI With TAVR, and Completeness of Revascularization)

Presenter: Jean-Michel Paradis

June 16, 2017

Presentation TVT 2017

The Role of MitraClip Therapy After TAVR Treatment Paradigms (Who, When, and How)

Presenter: Brij Maini

June 16, 2017

Presentation TVT 2017

Frequency and Clinical Management Issues in TAVR Patients

Presenter: John G. Webb

June 16, 2017

Presentation TVT 2017

A Call to Reason Clinical and Anatomic Situations Where TEE Provides Important Guidance During TAVR

Presenter: Axel Linke, Bernard Prendergast, G. Burkhard Mackensen

June 16, 2017

Presentation TVT 2017

Snapshot #2: Economic Benefits Associated With a TAVR Minimalist Approach

Presenter: Axel Linke, Bernard Prendergast, Hemal Gada

June 16, 2017

Presentation TVT 2017

Snapshot #1: Making the Transition to Awake TAVR - A Guide for Lower-Volume Centers

Presenter: Axel Linke, Bernard Prendergast, Kendra J. Grubb

June 16, 2017

Presentation TVT 2017

Potential Barriers to Adopting a Minimalist Transfemoral TAVR Pathway: Emerging Solutions and Future Directions (3M Trial Updates)

Presenter: Axel Linke, Bernard Prendergast, David A. Wood

June 16, 2017

Presentation TVT 2017

A Step-by-Step Analysis of the Minimalist TAVR Clinical Care Pathway: Components, Execution, and Advantages

Presenter: Axel Linke, Bernard Prendergast, Vinod H. Thourani

June 16, 2017

Presentation TVT 2017

How to Assess the Potential for LVOT Obstruction After TMV Replacement?

Presenter: Brian K. Whisenant, David W.M. Muller

June 15, 2017

Presentation TVT 2017

Fusion Imaging for Valve Intervention: Must Have or Nice to Have?

Presenter: Brian K. Whisenant, John D. Carroll

June 15, 2017

Presentation TVT 2017

Apical Access Surgical Technique: TAVR vs TMVR

Presenter: Brian K. Whisenant, Hendrik Treede

June 15, 2017

News Conference News TVT 2017

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Shelley Wood

June 15, 2017

Presentation TVT 2017

Techniques for Trans-septal Valve-in-Ring, Valve-in-Valve, and Valve-in-MAC

Presenter: Brian K. Whisenant, Mayra Guerrero

June 15, 2017

Presentation TVT 2017

MitraClip for Excluded Anatomy: How to Treat Clefts, Commissural MR, and More

Presenter: Brian K. Whisenant, Scott Lim

June 15, 2017

Advertisement

Who Shouldnt Undergo TAVR? Can We Identify Non-responders?

Ineffective Endocarditis After TAVR: Cause for Concern?

Gender Differences in TAVR Outcomes Recent Analyses in Intermediate-Risk Patients

TAVR in Patients With CKD: Diagnostic Workup, Valve Sizing, and Other Procedural Adjustments

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Management of Acute Coronary Syndromes and Left Main CAD in AS Patients: Case Examples and Procedural Techniques

Management of Stable Coronary Disease in AS Patients: Evolving Treatment Considerations (When to Consider CABG, Timing of PCI With TAVR, and Completeness of Revascularization)

The Role of MitraClip Therapy After TAVR Treatment Paradigms (Who, When, and How)

Frequency and Clinical Management Issues in TAVR Patients

A Call to Reason Clinical and Anatomic Situations Where TEE Provides Important Guidance During TAVR

Snapshot #2: Economic Benefits Associated With a TAVR Minimalist Approach

Snapshot #1: Making the Transition to Awake TAVR - A Guide for Lower-Volume Centers

Potential Barriers to Adopting a Minimalist Transfemoral TAVR Pathway: Emerging Solutions and Future Directions (3M Trial Updates)

A Step-by-Step Analysis of the Minimalist TAVR Clinical Care Pathway: Components, Execution, and Advantages

How to Assess the Potential for LVOT Obstruction After TMV Replacement?

Fusion Imaging for Valve Intervention: Must Have or Nice to Have?

Apical Access Surgical Technique: TAVR vs TMVR

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Techniques for Trans-septal Valve-in-Ring, Valve-in-Valve, and Valve-in-MAC

MitraClip for Excluded Anatomy: How to Treat Clefts, Commissural MR, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content